|
1
|
Lim S and Kaldis P: Cdks, cyclins and
CKIs: roles beyond cell cycle regulation. Development.
140:3079–3093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sánchez I and Dynlacht BD: New insights
into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol.
16:311–321. 2005.PubMed/NCBI
|
|
3
|
Sperka T, Wang J and Rudolph KL: DNA
damage checkpoints in stem cells, ageing and cancer. Nat Rev Mol
Cell Biol. 13:579–590. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Canavese M, Santo L and Raje N: Cyclin
dependent kinases in cancer: potential for therapeutic
intervention. Cancer Biol Ther. 13:451–457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van den Heuvel S and Dyson NJ: Conserved
functions of the pRB and E2F families. Nat Rev Mol Cell Biol.
9:713–724. 2008.PubMed/NCBI
|
|
6
|
Sun A, Bagella L, Tutton S, Romano G and
Giordano A: From G0 to S phase: a view of the roles played by the
retinoblastoma (Rb) family members in the Rb-E2F pathway. J Cell
Biochem. 102:1400–1404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lindqvist A, Rodríguez-Bravo V and Medema
RH: The decision to enter mitosis: feedback and redundancy in the
mitotic entry network. J Cell Biol. 185:193–202. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Porter LA and Donoghue DJ: Cyclin B1 and
CDK1: nuclear localization and upstream regulators. Prog Cell Cycle
Res. 5:335–347. 2003.PubMed/NCBI
|
|
9
|
Jeong AL and Yang Y: PP2A function toward
mitotic kinases and substrates during the cell cycle. BMB Rep.
46:289–294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ahuja I, Kissen R and Bones AM:
Phytoalexins in defense against pathogens. Trends Plant Sci.
17:73–90. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pedras MS and Ahiahonu PW: Metabolism and
detoxification of phytoalexins and analogs by phytopathogenic
fungi. Phytochemistry. 66:391–411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Toyomasu T, Kagahara T, Okada K, Koga J,
Hasegawa M, Mitsuhashi W, Sassa T and Yamane H: Diterpene
phytoalexins are biosynthesized in and exuded from the roots of
rice seedlings. Biosci Biotechnol Biochem. 72:562–567. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wickham KA and West CA: Biosynthesis of
rice phytoalexins: identification of putative diterpene hydrocarbon
precursors. Arch Biochem Biophys. 293:320–332. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chung IM, Kim JT and Kim SH: Evaluation of
allelopathic potential and quantification of momilactone A,B from
rice hull extracts and assessment of inhibitory bioactivity on
paddy field weeds. J Agric Food Chem. 54:2527–2536. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kato-Noguchi H and Ino T: Rice seedling
release momilactone B into the environment. Phytochemistry.
63:551–554. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chung IM, Hahn SJ and Ahmad A:
Confirmation of potential herbicidal agents in hulls of rice,
Oryza sativa. J Chem Ecol. 31:1339–1352. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chung IM, Ali M, Ahmad A, Chun SC, Kim JT,
Sultana S, Kim JS, Min SK and Seo BR: Steroidal constituents of
rice (Rryza sativa) hulls with algicidal and herbicidal
activity against blue-green algae and duckweed. Phytochem Anal.
18:133–145. 2007.PubMed/NCBI
|
|
18
|
Lee SC, Chung IM, Jin YJ, Song YS, Seo SY,
Park BS, Cho KH, Yoo KS, Kim TH, Yee SB, Bae YS and Yoo YH:
Momilactone B, an allelochemical of rice hulls, induces apoptosis
on human lymphoma cells (Jurkat) in a micromolar concentration.
Nutr Cancer. 60:542–551. 2008. View Article : Google Scholar
|
|
19
|
Kim SJ, Park HR, Park EJ and Lee SC:
Cytotoxic and antitumor activity of momilactone B from rice hulls.
J Agric Food Chem. 55:1702–1706. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Di X, Andrews DM, Tucker CJ, Yu L, Moore
AB, Zheng X, Castro L, Hermon T, Xiao H and Dixon D: A high
concentration of genistein down-regulates activin A, Smad3 and
other TGF-β pathway genes in human uterine leiomyoma cells. Exp Mol
Med. 44:281–292. 2012.PubMed/NCBI
|
|
21
|
Li Z and Gao Q: Induction of apoptosis in
HT-29 cells by quercetin through mitochondria-mediated apoptotic
pathway. Anim Cells Syst. 17:147–153. 2013. View Article : Google Scholar
|
|
22
|
Danova M, Giordano M, Mazzini G and
Riccardi A: Expression of p53 protein during the cell cycle
measured by flow cytometry in human leukemia. Leuk Res. 14:417–422.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pavletich NP: Mechanisms of
cyclin-dependent kinase regulation: structures of Cdks, their
cyclin activators, and Cip and INK4 inhibitors. J Mol Biol.
287:821–828. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Galons H, Oumata N and Meijer L:
Cyclin-dependent kinase inhibitors: a survey of recent patent
literature. Expert Opin Ther Pat. 20:377–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Matsuda Y and Ichida T: p16 and p27 are
functionally correlated during the progress of
hepatocarcinogenesis. Med Mol Morphol. 39:169–175. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee MH and Yang HY: Negative regulators of
cyclin-dependent kinases and their roles in cancers. Cell Mol Life
Sci. 58:1907–1922. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abbas T and Dutta A: p21 in cancer:
intricate networks and multiple activities. Nat Rev Cancer.
9:400–414. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gartel AL and Tyner AL: The role of the
cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer
Ther. 1:639–649. 2002.PubMed/NCBI
|
